Medical Field Advisor, Benelux & North of France Contractor

Location(s): Amsterdam, Netherlands

Level of position: Associate Director

Position type: 50% Office-based, 50% Field-based

Scope: Expected to support the Netherlands 70%, Belgium 15% & North of France 15%

Reporting Line: International Medical Director (from 2025 onwards), ai Medical Director Spain

 

How will your role help us transform hope into reality?

At Blueprint Medicines, we are creating a blueprint for the future of healthcare – embracing a personalized medicine revolution by focusing on delivering new medicines that are targeted to the genetic driver of disease. We do this by leveraging our one-of-a-kind drug discovery platform to discover, develop and work to bring highly selective kinase inhibitors to patients globally.  This prolific scientific platform has enabled Blueprint Medicines to build a pipeline of novel therapies that span three distinct areas of medicine; genomically defined cancers, rare diseases and cancer immunotherapy. Reporting to the International Medical Director (ai to Medical Director Spain), and dotted line to the VP & General Manager France and Mid Size Countries the Medical Field Advisor Benelux & North of France.

What will you do?

HCP (health care provider) outreach:

• Deep knowledge of the country's KOLs landscape, proactively manages KOL pool in the interest of Blueprint at the country level
• Establish and maintain strong relationships with, and be recognized by KOLs, HCPs and PI’s as Blueprint reference point and connector.
• Drives engagement of HCPs, professional societies and other key customers, including patients advocacy groups.
• Fosters the establishment and maintenance of local scientific advisory boards, round tables, expert meetings and scientific advocacy development.

 Scientific and Medical Affairs expertise:

• Develops and maintains scientific and medical and scientific knowledge and maintains an awareness of relevant industry and market trends (i.e., competitive, technological, social and economic).
• Participates in gathering clinical insights, needs and feedback from medical specialists and other stakeholders in the market, acts upon them and communicates to/shares with internal partners
• Remains informed of current developments within pertinent medical and scientific communities through familiarity with current literature, attendance at meetings, conventions, professional associations, etc.
• Works closely with local, regional and global market access colleagues in preparing strong price and reimbursement dossiers that will be tested extensively with medical experts and national leaders. May also have to represent it to reimbursement authorities.
• Alignment with the Global and EU/International team on plans and processes.
• Drives the local Medical Plan development and its execution
• Actively supports upcoming launches by the means of Blueprint Medicines company sponsored symposia and other activities.
• Reviews and signs off local educational and promotional material as the responsible information officer for the corresponding indication and of clinical trial treatment plans and protocols of Phase IV projects in line with local compliance regulations.

Data Generation and Clinical trial support:

• Supports interventional and non-Interventional clinical trials in close collaboration with with Clinical development-, Clinical Operations- and Global Medical Affairs teams. Ensures a strategic approach to such programs, and the development of clinical data to support the appropriate use of the Company's products.
• Works with colleagues of Blueprint Medicines International headquarter in Zug and other countries in the international region to ensure consistency of clinical programs from a medical perspective.
• Ensures that Investigator Initiated Research studies are in line with the global strategy. Helps to detect need for and enables Real World Evidence generation when required for advancing therapeutic area a/o for access needs.
• Collaborates closely with market access for HEOR, access required information

 

 What minimum qualifications do we require?

• Minimum 8 years in Medical Affairs positions (MSL, Medical Advisor/Manager) in Belgium and/or Netherlands is required.
• Advanced Doctoral or Scientific degree required

 

What additional qualifications will make you a stronger candidate?

• Understanding of pharmaceutical commercial, access, medical and scientific needs on a local basis.
• Experience with product launches.
• Solid knowledge of Netherlands and Belgium regulations, guidelines, codes of practices and Access requirements
• Operational excellence: management skills, planning, prioritization, decision making, objective setting and plan execution.
• Strong customer orientation; science-based, but good understanding of marketing needs; negotiation skills.
• Solid peer relationships with exposure to scientific and clinical experts, with a demonstrated ability to engage internal and external leaders.
• Experience delivering effective and persuasive communications on complex and controversial matters to both corporate management and scientific audiences.
• Demonstrable experience in the implementation of launches (pre and post-launch plans).
• Solid understanding of the capabilities of the medical affairs function in general, the Hematology/Oncology/Allergology medical environment as well as Regulatory, HTA, Early Access Program and RCTs requirements.
• Ability to maintain scientific credibility through effective scientific communication
• Superior ability and leadership presence to represent Blueprint Medicines in the medical community as an ambassador.
• Has confidence and optimism, enabling the development of strong relationships internally and externally with executive level leaders.
• Demonstrates respect for others by seeking to understand how they think about issues/opportunities; has an appreciation for others’ strengths/development areas to increase overall collaboration and performance, is able to listen attentively.
• Seeks input from team to make key decisions while ensuring final decisions are reached quickly and effectively.
• Has strong business acumen and courage of one’s convictions; however, stands by organizational decisions once made.
• Ability to create and implement strategic plans in a “green field” environment, can prioritize and execute independently, is a self-starter and has a ‘sleeves rolled up’ approach. Entrepreneurial and innovative of spirit.
• High degree of emotional intelligence, displaying candor and integrity at all times, combined with the ability to manage complexity, ambiguity and paradoxes during the built-out of the Italy/Iberia region.
• Excellent written and oral communication skills in Dutch, French and English, including strong formal presentation skills in those languages.
• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

 

Why Blueprint? 

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.

*Blueflex is our operating model which optimizes culture, productivity, & flexibility by maximizing the critical strengths of in-person work with the benefits of added flexibility.  Blueflex allows for mix of in-office and remote work, enables flexibility to meet individual and business needs and makes effective use of our facilities and resources.  It is a culture enhancer.

#LI-Hybrid 

#LI-NJ1